FDA advisers are reviewing a multicancer-detection test. Medicare coverage could follow.
marketwatch.com
23.09.2026 14:39
6 views
Grail’s Galleri test looks for 50 cancers from a blood draw, but a major study failed to prove it could detect later-stage cancers.
Related stories
Why is the price of protein powder rising?
bbc.co.uk · 23.09
Palantir’s stock is heading for its highest close of the year, in a dramatic comeback
marketwatch.com · 23.09
The ingredients for a financial reckoning are all in place
marketwatch.com · 23.09
Businesses are growing at the fastest pace in over four years. Why war and inflation aren’t slowing the U.S. economy down.
marketwatch.com · 23.09
McDonald’s is making a historic bet on chicken — and AI — to bring back customers
marketwatch.com · 23.09
Fuel prices keep rising — and so do Democrats’ chances of winning both the House and Senate
marketwatch.com · 23.09